Wolff-Parkinson-White syndrome in pregnancy: a case report
DOI:
https://doi.org/10.18203/2349-3933.ijam20222673Keywords:
WPW, Tachyarrthymias, Antiarrthymic drugsAbstract
Wolff-Parkinson-White (WPW) syndrome is a rare congenital cardiac pre-ex citation syndrome encountered during pregnancy. However, WPW under this physiological process might be responsible for life threatening arrthymias leading to dangerous outcomes for both mother and the fetus. It is a ventricular pre-excitation syndrome of anterograde activation of the ventricle resulting from aberrant conduction pathway as well as the AV node. Very small percent of patients with WPW syndrome that is less than 1% are at risk of sudden cardiac death. Most of the antiarrthymic drugs are a threat to the fetus therefore careful choice of drug has to be made. Digoxin is the drug that is contraindicated in adults with WPW syndrome and some drugs like verapamil increase danger of ventricular fibrillation and therefore use of drugs are a topic of concern. We present a case of 25-year-old primi gravida 31 weeks 5 days woman was admitted with oligohydramnios. Patient known case of WPW syndrome not on treatment showing ECG changes of short PR interval and delta wave slurring along the QRS complex with heart rate of 98 beats/ min and echo demonstrated mild tricuspid regurgitation (TR) and mild pulmonary arterial hypertension (PAH). Patient was taken for emergency LSCS in view of Doppler changes (CPR less than 1) and delivered an alive preterm baby.
References
Population Challenges and Development Goals, Department of Economic and Social Affairs, Population Division. United Nations New York. 2005.
Srivastav A, Khan MS, Chauhan CR. Knowledge, attitude and practices about contraceptive among married reproductive females. Int J Scientific Study. 2014;1(5):2-4.
Tuladhar H, Marahatta R. Awareness and practice of family planning methods in women attending gyne OPD at Nepal Medical College Teaching Hospital. Nepal Med Coll J. 2008;10(3):184-91.
Bongaarts J. The KAP- Gap and Unmet need for contraception. Population and Devt Rev. 1991;17:293-313.
Gaikwad R, Gadappa S, Deshpande S. Awareness of contraception in post-partum women in a tertiary care centre. Int J Reproduct Contracept Obstetr Gynecol. 2017;6(9):3850.
Singh K, Verma S, Tanti S. Contraceptive use among postpartum women in India. Asian Population Studies. 2013;10:23-39.
Stover J, Ross J. How increased contraceptive use has reduced maternal mortality. Matern Child Health J. 2010;14(5):687-95.
Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis. JAMA. 2006;295(15):1809-23.
Elkayam U, Goodwin TM. Adenosine therapy for supraventricular tachycardia during pregnancy. Am J. 1995;25.
Bourget P, Pons JC, Delouis C, Fermont L, Frydman R. Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy. Ann Pharmacotherapy. 1994;28(9).
Hosl P, Rust M, Johannigmann J, Schmidt G. Treatment ofparoxysmal supraventricular tachycardia during pregnancy. Geburtshilftachycardia Frauenheilkunde. 1996;56(6):313-6.
ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;26.
Thapa S, Rani A, Mishra CP. Knowledge, attitude and belief about contraception in post-partum and post abortal women in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2014;3(3):533-9.
Hidaka N, Chiba Y, Fukushima K, Wake N. Pregnant Women with Complete Atrioventricular Block: Perinatal Risks and Review of Management. Pacing Clin Electrophysiol. 2011;34:1161-76.
Beckman CRB, Ling FW, Barzansky BM, Herbert NP, Laube DW, Smith RP. Obstetrics and Gynecology. 6th Edition, Lippincott Williams and Wilkins, Philadelphia. 2010.
Damilakis J, Theocharopoulos N, Perisinakis K, Manios E, Dimitriou P, Vardas P, Gourtsoyiannis N. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation. 2011;104(8):893-7.
Szumowski L, Szufladowicz E, Orczykowski M, Bodalski R, Derejko P, Przybylski A et al. Ablation of severe drug‐ resistant tachyarrhythmia during pregnancy. J Cardiovascular Electrophysiol. 2010;21(8):877-82.
